» Articles » PMID: 22268405

Discussions of Life Expectancy Moderate Relationships Between Prognosis and Anxiety or Depression in Men with Advanced Cancer

Overview
Journal J Palliat Med
Specialty Critical Care
Date 2012 Jan 25
PMID 22268405
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Oncologists avoid prognostic discussions due to concerns about increasing patients' anxiety or depression. We sought to determine if perceived prognosis or extent of prognostic discussions predicted anxiety or depression and whether prognostic discussions moderated the relationship between prognosis and anxiety or depression.

Methods: Men with advanced cancer and their oncologists estimated the likelihood of survival at 6 months and reported extent of prognostic discussions. Anxiety and depression were measured by the Hospital Anxiety and Depression Scale (HADS).

Results: Men who died within 6 months reported higher scores on depression but not anxiety. Men who estimated a lower (10%-75%) likelihood of surviving at least 6 months were more depressed and anxious than men who estimated a higher (>90%) likelihood of survival. A similar relationship was seen with oncologists' prognostications. Men who reported having had full prognostic discussions with their oncologist had less depression compared with men who reported having had brief or no discussions. Men for whom the oncologists reported a full discussion had greater anxiety. The relationships between patient-perceived prognosis and depression or anxiety were moderated by extent of prognostic discussions as reported by the patient or oncologist, respectively.

Conclusion: Full prognostic discussions are associated with less depression among men who perceive a poor prognosis. Anxiety is increased in men if the oncologists report a full discussion. Oncologists should engage in prognostic discussions but assess for increased anxiety to facilitate coping with advanced cancer.

Citing Articles

Lessons Learned From Shared Decision-Making With Oral Anticoagulants: Viewpoint on Suggestions for the Development of Oral Chemotherapy Decision Aids.

McLoughlin D, Moreno Echevarria F, Badawy S JMIR Cancer. 2024; 10:e56935.

PMID: 39187430 PMC: 11425020. DOI: 10.2196/56935.


Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial.

van de Water L, Bos-van den Hoek D, Kuijper S, van Laarhoven H, Creemers G, Dohmen S Med Decis Making. 2023; 44(1):89-101.

PMID: 37953598 PMC: 10712204. DOI: 10.1177/0272989X231208448.


Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.

van der Velden N, Han P, van Laarhoven H, de Vos F, Hendriks L, Burgers S Oncologist. 2023; 28(8):e653-e668.

PMID: 37159001 PMC: 10400164. DOI: 10.1093/oncolo/oyad098.


The Effect of Prognostic Communication on Patient Outcomes in Palliative Cancer Care: a Systematic Review.

van der Velden N, Meijers M, Han P, van Laarhoven H, Smets E, Henselmans I Curr Treat Options Oncol. 2020; 21(5):40.

PMID: 32328821 PMC: 7181418. DOI: 10.1007/s11864-020-00742-y.


Why many oncologists fail to share accurate prognoses: They care deeply for their patients.

Abernethy E, Campbell G, Pentz R Cancer. 2019; 126(6):1163-1165.

PMID: 31774548 PMC: 7050325. DOI: 10.1002/cncr.32635.